Table 4.
Comparison of serum magnesium values at the initial visit, first month, and second month of treatment within the kanamycin-based and capreomycin-based groups.
| Initial visit Mean ± SD (mg/dL) |
First month Mean ± SD (mg/dL) |
Second month Mean ± SD (mg/dL) |
p value | ||
|---|---|---|---|---|---|
| Kanamycin | N | 34 | 34 | 34 | <0.001 a |
| Magnesium | 2.33 ± 0.21 | 2.11 ± 0.20 | 2.11 ± 0.23 | ||
| Difference | — | −0.22 | −0.22 | ||
| p value | — | <0.001 b ∗ | <0.001 b ∗ | ||
|
| |||||
| Capreomycin | N | 19 | 19 | 19 | 0.083a |
| Magnesium | 2.23 ± 0.18 | 2.13 ± 0.34 | 1.96 ± 0.51 | ||
| Difference | — | −0.10 | −0.27 | ||
| p value | — | 0.814b | 0.056b | ||
SD, standard deviation; analyzed using aone-way ANOVA with the post hoc bBonferroni test.